Another drug manufacturer settles with dozens of states over price-fixing allegations
Generic drug manufacturer Glenmark will pay Oregon $316,000 as part of a $29.6 million settlement for participating in a price-fixing scheme that inflated prescription drug costs for consumers across the country.